Position in REGN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$121,907,911
-$2,212,644 QoQ
Shares Held
157,781
-1.9% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 60.45848359434913.ToString("F0")%
Shared 0.ToString("F0")%
None 39.541516405650874.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,828,718 across 284 Biotechnology names. REGN ranks #2 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $121,907,911 | 157,781 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $124,120,555 | 160,805 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $94,461,922 | 168,001 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $89,595,975 | 170,659 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $109,827,706 | 173,167 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $121,537,744 | 170,620 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $183,699,985 | 174,746 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $189,287,349 | 180,097 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $176,681,401 | 183,567 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $159,495,707 | 181,598 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $150,830,462 | 183,278 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $133,700,893 | 186,073 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $150,944,065 | 183,704 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $135,571,578 | 187,905 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $123,306,352 | 178,998 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $102,604,207 | 173,573 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $113,930,460 | 163,126 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $102,305,608 | 161,999 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $97,595,563 | 161,267 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $90,367,303 | 161,792 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $78,186,385 | 165,250 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $84,000,268 | 173,874 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $107,969,246 | 192,878 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $122,171,164 | 195,897 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $71,509,582 | 146,449 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||